REGULATION OF SIMIAN FOAMY VIRUS GENE EXPRESSION
猿泡沫病毒基因表达的调控
基本信息
- 批准号:3145532
- 负责人:
- 金额:$ 17.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-07-01 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The foamy viruses, or syncytium-forming viruses, are members of the
spumaviriniae sub-family of retroviruses. Foamy viruses are found in
many mammalian species and appear to be non-pathogenic in their natural
hosts even though they have a wide tissue range and induce extensive
cytopathology in cell cultures. The genomes of simian foamy virus type 1
(SFV-l) from rhesus macaque and human spumaretrovirus (HSRV) have been
molecularly cloned and sequenced; pairwise comparisons of these two
viruses show from 30% to 80% homology, depending on the region selected
for analysis. Both viruses encode several open reading frames (ORFs) in
addition to genes for virion structural proteins. Recent studies have
revealed that SFV-1 and HSRV each encode a transactivator (taf) which
functions to strongly augment transcription directed by the viral long
terminal repeat (LTR). The main objective of this proposal is to
elucidate molecular mechanisms regulating SFV-1 gene expression directed
by the viral LTR. It remains to be determined whether taf acts directly
on the LTR or whether transactivation is mediated by cellular factors.
The target (TAR) for taf is distributed over two parts of the U3 domain
of the viral LTR upstream from the TATA box in the viral promoter. Each
these two TAR regions is about 300 base pairs (bp) long and no homologies
(i.e., repeat elements) are detected between the two TARs. In addition,
the promoter-distal TAR (TAR-d) functions in only in the sense
orientation whereas the promoter-proximal TAR (TAR-p) functions in either
orientation. These observations (on the complex nature of the targets)
support the hypothesis that taf may function through more than one
cellular factor which interacts with different sequence elements in the
U3 region of the LTR.
SPECIFIC AIM 1: Binding sites for cellular factors and the precise target
sequences for taf in the SFV-1 LTR will be defined.
SPECIFIC AIM 2: Monospecific antibodies will be made to detect the SFV-1
taf gene product; taf protein in infected cells will be extensively
characterized.
SPECIFIC AIM 3: Genetically engineered yeast and mammalian cells will be
used to produce the SFV-1 taf gene product for structural and functional
studies.
SPECIFIC AIM 4: To elucidate the mechanism of SFV-1 transcriptional
transactivation, functional domains of taf will be identified by
mutagenesis and by evaluation of hybrid transactivators.
These studies on SFV-1 regulation are relevant for elucidating mechanisms
which control viral latency (or persistent infection) in the host animal.
Observations made in the course of the proposed research will also
enhance the understanding of mechanisms controlling eucaryotic
transcription; the proposed studies on SFV-1 gene expression are
significant since new (cellular) transcriptional factors may be
identified.
泡沫病毒,或合胞体形成病毒,是
海绵病毒亚科逆转录病毒。泡沫状病毒在
许多哺乳动物物种,似乎在他们的天然非致病
寄主,尽管它们具有广泛的组织范围并诱导广泛的
细胞培养中的细胞病理学。猴泡沫病毒1型基因组的研究
来自恒河猴的L病毒和人类Spumaretrov已经被
分子克隆和测序;这两者的配对比较
病毒的同源性在30%到80%之间,具体取决于所选择的区域
以供分析。这两种病毒都编码了几个开放阅读框架(ORF)
病毒粒子结构蛋白基因的补充。最近的研究表明
揭示了SFV-1和HSRV各自编码一个反式激活因子(Taf),Taf
强烈增强病毒Long引导的转录的功能
终端重复(LTR)。这项建议的主要目的是
定向调控SFV-1基因表达的分子机制
被病毒LTR感染。Taf是否直接起作用还有待确定
或者反式激活是否由细胞因子介导。
Taf的目标(TAR)分布在U3域的两个部分
病毒启动子中TATA盒上游的病毒LTR。每个人
这两个TAR区长约300个碱基对,没有同源性
(即,在两个TAR之间检测到重复元件)。此外,
启动子-远端TAR(tar-d)仅在某种意义上起作用
而启动子-近端TAR(TAR-P)在以下两种情况下都起作用
定位。这些观察(关于目标的复杂性质)
支持Taf可能通过不止一个途径发挥作用的假设
与不同序列元件相互作用的细胞因子
LTR的U3区。
特异性目标1:细胞因子的结合位点和精确靶点
将定义SFV-1 LTR中Taf的序列。
特异性目的2:制备单特异性抗体用于检测SFV-1
Taf基因产物;Taf蛋白在感染细胞中将广泛表达
特色化的。
特定目的3:基因工程酵母和哺乳动物细胞将
用于生产SFV-1 Taf基因产物,用于结构和功能
学习。
特异性目的4:阐明SFV-1转录调控机制
Taf的反式激活、功能结构域将通过
突变和杂合反式激活剂的评价。
这些关于SFV-1调控的研究对于阐明机制是相关的。
它们控制宿主动物中的病毒潜伏期(或持续感染)。
在拟议的研究过程中提出的意见也将
加深对真核生物调控机制的理解
转录;建议对SFV-1基因表达的研究包括
由于新的(细胞)转录因子可能是
确认身份。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Luciw其他文献
Paul Luciw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Luciw', 18)}}的其他基金
Nonhuman Primate Model for Eradication Therapy
用于根除治疗的非人类灵长类动物模型
- 批准号:
8326805 - 财政年份:2011
- 资助金额:
$ 17.66万 - 项目类别:
IMMUNOASSAYS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
检测结核分枝杆菌的免疫测定法
- 批准号:
8172553 - 财政年份:2010
- 资助金额:
$ 17.66万 - 项目类别:
IMMUNOASSAYS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
检测结核分枝杆菌的免疫测定法
- 批准号:
7959047 - 财政年份:2009
- 资助金额:
$ 17.66万 - 项目类别:
PHARMACOKINETIC STUDY OF PROSTRATIN AND PRODRUG
前列腺素及其前药的药代动力学研究
- 批准号:
7715650 - 财政年份:2008
- 资助金额:
$ 17.66万 - 项目类别: